{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:02:36Z","timestamp":1790265756817,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0343"],"award-info":[{"award-number":["P3-0343"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12888-019-2047-1","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T09:05:15Z","timestamp":1549875915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The use of quetiapine in treatment of acute psychotic symptoms in an adolescent patient with primary brain calcification: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Barbara","family":"Plemeniti Tololeski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maru\u0161a","family":"Debeljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Perkovi\u010d Benedik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Rigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinos","family":"Kyriakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primo\u017e","family":"Kotnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"\u0160urlan Popovi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0906-1710","authenticated-orcid":false,"given":"Maja","family":"Drobni\u010d Radobuljac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"2047_CR1","doi-asserted-by":"publisher","first-page":"22961","DOI":"10.1038\/srep22961","volume":"6","author":"JRM Oliveira","year":"2016","unstructured":"Oliveira JRM, Oliveira MF. Primary brain calcification in patients undergoing treatment with the biphosphanate alendronate. Sci Rep. 2016;6:22961. \n                    https:\/\/doi.org\/10.1038\/srep22961\n                    \n                  .","journal-title":"Sci Rep"},{"key":"2047_CR2","unstructured":"Ramos EM, Oliveira J, Sobrido MJ, et al. Primary Familial Brain Calcification. 2004 Apr 18 [Updated 2017 Aug 24]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1421\/\n                    \n                  . Accessed October 28, 2018."},{"issue":"2","key":"2047_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/mds.1049","volume":"16","author":"BV Manyam","year":"2001","unstructured":"Manyam BV, Walters AS, Narla KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Movement disorder. 2001;16(2):258\u201364. \n                    https:\/\/doi.org\/10.1002\/mds.1049\n                    \n                  .","journal-title":"Movement disorder"},{"issue":"5","key":"2047_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10072-005-0493-7","volume":"26","author":"PJ Modrego","year":"2005","unstructured":"Modrego PJ, Mojonero J, Serrano M, Fayed N. Fahr's syndrome presenting with pure and progressive presenile dementia. Neurol Sci. 2005;26(5):367\u20139. \n                    https:\/\/doi.org\/10.1007\/s10072-005-0493-7\n                    \n                  .","journal-title":"Neurol Sci"},{"key":"2047_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1176\/jnp.10.3.249","volume":"10","author":"EC Lauterbach","year":"1998","unstructured":"Lauterbach EC, Cummings JL, Duffy J, Coffey CE, Kaufer D, Lovell M, et al. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA committee on research. American neuropsychiatric association. J Neuropsychiatry Clin Neurosci. 1998;10:249\u201366. \n                    https:\/\/doi.org\/10.1176\/jnp.10.3.249\n                    \n                  .","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"209","key":"2047_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.31729\/jnma.1600","volume":"56","author":"S Subedi","year":"2018","unstructured":"Subedi S, Mukhi S, Pandey P. Fahr's disease presenting with manic symptoms. JNMA J Nepal Med Assoc. 2018;56(209):553\u20135.","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"9","key":"2047_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.braindev.2013.12.005","volume":"36","author":"M Ishitobi","year":"2014","unstructured":"Ishitobi M, Kawatani M, Asano M, Kosaka H, Goto T, Hiratani M, Wada Y. Quetiapine responsive catatonia in an autistic patient with comorbid bipolar disorder and idiopathic basal ganglia calcification. Brain Dev. 2014;36(9):823\u20135. \n                    https:\/\/doi.org\/10.1016\/j.braindev.2013.12.005\n                    \n                  .","journal-title":"Brain Dev"},{"issue":"6","key":"2047_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1176\/appi.psy.46.6.569","volume":"46","author":"SV Shakibai","year":"2005","unstructured":"Shakibai SV, Johnson JP, Bourgeois JA. Paranoid delusions and cognitive impairment suggesting Fahr's disease. Psychosomatics. 2005;46(6):569\u201372. \n                    https:\/\/doi.org\/10.1176\/appi.psy.46.6.569\n                    \n                  .","journal-title":"Psychosomatics"},{"key":"2047_CR9","first-page":"591","volume":"18","author":"JL Cummings","year":"1983","unstructured":"Cummings JL, Gosenfeld LF, Houlihan JP, McCaffrey T. Neuropsychiatrc disturbances associated with idiopathic calcification of the basal ganglia. Biol Psychiatry. 1983;18:591\u2013601.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2047_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2165\/00023210-200418030-00004","volume":"18","author":"SM Cheer","year":"2004","unstructured":"Cheer SM, Wagstaff AJ. Quetiapine. A review of its use in the management of schizophrenia. CNS Drugs. 2004;18(3):173\u201399. \n                    https:\/\/doi.org\/10.2165\/00023210-200418030-00004\n                    \n                  .","journal-title":"CNS Drugs"},{"key":"2047_CR11","first-page":"63","volume":"2","author":"S Kono","year":"2009","unstructured":"Kono S, Manabe Y, Tanaka T, Fujii D, Sakai Y, Narai H, Omori N, et al. A case of Fahr's disease presenting as chorea successfully treated by the use of quetiapine. Clin Med Case Rep. 2009;2:63\u20135 https:\/\/doi.org\/10.4137%2FCCRep.S3423.","journal-title":"Clin Med Case Rep"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-019-2047-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T19:06:34Z","timestamp":1581361594000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-019-2047-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2047"],"URL":"https:\/\/doi.org\/10.1186\/s12888-019-2047-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"11 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from the patient. No identifiable information was made available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"67"}}